Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance
(NASDAQ: ABVX) Delayed: 105.04 -1.95 (1.82%)
Previous Close $106.99    52 Week High $ 
Open $107.00    52 Week Low $ 
Day High $107.19    P/E N/A 
Day Low $103.89    EPS $ 
Volume 876,031       

(NASDAQ: ABVX) Delayed: 105.04 -1.95 (1.82%)
Previous Close $106.99    52 Week High $ 
Open $107.00    52 Week Low $ 
Day High $107.19    P/E N/A 
Day Low $103.89    EPS $ 
Volume 876,031